Clinical trials
Phase 3 Immunoglobulin Light-chain Amyloidosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2015 | 2 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 2 |
| Alliance for Clinical Trials in Oncology | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Mayo Clinic | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Boston Medical Center | 1 |
| Case Comprehensive Cancer Center | 1 |
| INSYS Therapeutics Inc | 1 |
| Lantheus Germany GmbH | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 19 |
| Multiple Myeloma | 12 |
| Hodgkin Disease | 10 |
| Immunoblastic Lymphadenopathy | 10 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Follicular | 10 |
| Lymphoma, Large B-Cell, Diffuse | 10 |
| Lymphoma, Large-Cell, Anaplastic | 10 |
| Lymphoma, Large-Cell, Immunoblastic | 10 |
| Lymphoma, Mantle-Cell | 10 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.